Section Arrow
SBFM.NASDAQ
- Sunshine Biopharma
(Financial Status)
Quotes are at least 15-min delayed:2024/05/11 00:51 EDT
Last
 0.8925
-0.0205 (-2.25%)
Day High 
0.9449 
Prev. Close
0.913 
1-M High
10 
Volume 
1.69M 
Bid
0.878
Ask
0.89
Day Low
0.8533 
Open
0.9002 
1-M Low
0.75 
Market Cap 
908.00K 
Currency USD 
P/E -- 
%Yield
10-SMA 0.91 
20-SMA 2.17 
50-SMA 5.03 
52-W High 140 
52-W Low 0.75 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-19.00/--
Enterprise Value
1.45M
Balance Sheet
Book Value Per Share
21.32
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
24.09M
Operating Revenue Per Share
14.61
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
TLRYTilray Brands1.93-0.05-2.53%-- 
TEVATeva Pharmaceutical Industries Limited16.25+0.25+1.56%-- 
AKANAkanda Corp0.0982+0.0067+7.32%-- 
CGCCanopy Growth Corp9.05-0.81-8.22%-- 
VTRSViatris11.16-0.06-0.53%224.4PE
Quotes are at least 15-min delayed:2024/05/11 00:51 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. The company is conducting a proprietary drug development program which is comprised of (i) K1.1 mRNA targeted for liver cancer, (ii) SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections, and (iii) Adva-27a for pancreatic cancer. The company has two reportable segments: Prescription Generic Pharmaceuticals ("Generic Pharmaceuticals") and Nonprescription Over-The-Counter Products ("OTC Products"). The company generates the majority of its revenue from the Generic Pharmaceuticals segment.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.